Original Article
You have full text access to this OnlineOpen article
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis
Article first published online: 30 DEC 2003
DOI: 10.1053/jhep.2001.27093
Copyright © 2001 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Cejudo-Martín, P., Ros, J., Navasa, M., Fernández, J., Fernádez-Varo, G., Ruiz-del-Arbol, L., Rivera, F., Arroyo, V., Rodés, J. and Jiménez, W. (2001), Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 34: 487–493. doi: 10.1053/jhep.2001.27093
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 20 JUN 2001
- Manuscript Received: 13 MAR 2001
Funded by
- Dirección General de Investigación Cientófica y Técnica. Grant Number: SAF99-0016, to W.J.
- Fondo de Investigación Sanitaria to J.R. and V.A., respectively. Grant Numbers: FIS 00/0398, FIS 00/0616
- IDIBAPS
- DGICYT. Grant Number: SAF99-0016
- Hospital Clínic.
References
- 1, . Infections in liver disease. In: BircherJ, BenhamouJP, McIntyreN, RizzettoM, RodésJ, eds. Oxford Textbook of Clinical Hepatology. New York: Oxford University Press, 1999;1862–1874.
- 2
- 3, , , , , , , et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17:251–257.MEDLINE
- 4, , , , , , , et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27:1227–1232.MEDLINE
- 5, , . Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999; 6:83–96.MEDLINE
- 6
- 7, , , , , , , et al. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 1999; 29:1057–1063.MEDLINE
- 8, . A simple method for the purification of human peripheral blood monocytes. A substitute for sepracell-MN. J Immunol Methods 1991; 144:247–251.MEDLINE
- 9, , , , , , , et al. Effect of bacterial lipopolysaccharide on Endothelin-1 production in human vascular endothelial cells. J Hepatol 1997; 26:81–87.MEDLINE
- 10
- 11, , , , , . The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5:1806–1814.MEDLINE
- 12, , , , , , . Increased DNA methyltransferase expression in rhabdomyosarcomas. Int J Cancer 1999; 83:10–14.MEDLINE
- 13
- 14, , . Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med 1996; 2:583–596.MEDLINE
- 15, , , , . Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990; 5:519–524.MEDLINE
- 16, , , , , , . Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992; 187:1579–1586.MEDLINE
- 17, , , , , , , et al. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol 1997; 150:1673–1685.MEDLINE
- 18, , , , , , , et al. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol 1997; 27:854–861.MEDLINE
- 19, , , , , , , et al. Interactions between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression. Atherosclerosis 2000; 150:63–70.MEDLINE
- 20, , , , . Vascular endothelial growth factor (VEGF) in Crohn's Disease: Dig Dis Sci 1999; 44:1196–1201.MEDLINE
- 21, , , , . Milky spots in the mouse omentum may play an important role in the origin of peritoneal macrophages. Res Immunol 1992; 143:401–409.MEDLINE
- 22, , , , , , . Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study. Anat Rec 1995; 241:163–174.MEDLINE
- 23, , , , . Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 1997; 62:397–400.MEDLINE
- 24, , , , , , , et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995; 55:4140–4145.MEDLINE
- 25, . The biology of vascular endothelial growth factor. Endocrine Rev 1997; 18:4–25.
- 26. Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNFα antibody in rheumatoid arthritis. Mol Pathol 1997; 50:225–233.MEDLINE
- 27, , , . Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes. J Invest Dermatol 1997; 108:523–526.MEDLINE
- 28
- 29, , , , , , . Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 1994; 51:524–530.MEDLINE
- 30, , , , , . Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87:3336–3343.MEDLINE
- 31, , , , , , , et al. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun 1995; 209:218–226.MEDLINE
- 32, , , . Activation of Mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of Prolactin. Proc Natl Acad Sci U S A 1995; 92:6374–6378.MEDLINE
- 33, , , , , , . VEGF121 a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995; 270:11322–11326.MEDLINE

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)